SMT201600284B - Nuovi derivati di ammino-pirrolina, e loro usi nella prevenzione e/o nel trattamento della sindrome metabolica - Google Patents

Nuovi derivati di ammino-pirrolina, e loro usi nella prevenzione e/o nel trattamento della sindrome metabolica

Info

Publication number
SMT201600284B
SMT201600284B SM201600284T SM201600284T SMT201600284B SM T201600284 B SMT201600284 B SM T201600284B SM 201600284 T SM201600284 T SM 201600284T SM 201600284 T SM201600284 T SM 201600284T SM T201600284 B SMT201600284 B SM T201600284B
Authority
SM
San Marino
Prior art keywords
pyrrolin
prevention
derivatives
treatment
metabolic syndrome
Prior art date
Application number
SM201600284T
Other languages
English (en)
Inventor
Pascal Bousquet
Jean Daniel Ehrhardt
Lyne Fellmann
Vincent Gasparik
Hugues Greney
Mohamed Hadjeri
Andre Mann
Nathalie Niederhoffer
Stephan Schann
Original Assignee
Univ Strasbourg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1153375A external-priority patent/FR2974364B1/fr
Application filed by Univ Strasbourg filed Critical Univ Strasbourg
Publication of SMT201600284B publication Critical patent/SMT201600284B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM201600284T 2011-04-19 2016-08-23 Nuovi derivati di ammino-pirrolina, e loro usi nella prevenzione e/o nel trattamento della sindrome metabolica SMT201600284B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1153375A FR2974364B1 (fr) 2011-04-19 2011-04-19 Nouveaux derives amino-pyrroliniques, leur utilisation dans la prevention et/ou le traitement du syndrome metabolique
FR1251302 2012-02-13
PCT/FR2012/050835 WO2012143660A1 (fr) 2011-04-19 2012-04-17 Nouveaux derives amino-pyrroliniques, leur utilisation dans la prevention et/ou le traitement du syndrome metabolique

Publications (1)

Publication Number Publication Date
SMT201600284B true SMT201600284B (it) 2016-11-10

Family

ID=46146922

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600284T SMT201600284B (it) 2011-04-19 2016-08-23 Nuovi derivati di ammino-pirrolina, e loro usi nella prevenzione e/o nel trattamento della sindrome metabolica

Country Status (17)

Country Link
US (1) US9303019B2 (it)
EP (1) EP2699545B1 (it)
JP (1) JP5986625B2 (it)
CN (1) CN103619814B (it)
CA (1) CA2833339C (it)
CY (1) CY1118117T1 (it)
DK (1) DK2699545T3 (it)
ES (1) ES2588059T3 (it)
HR (1) HRP20161024T1 (it)
HU (1) HUE030432T2 (it)
LT (1) LT2699545T (it)
PL (1) PL2699545T3 (it)
PT (1) PT2699545T (it)
RS (1) RS55061B1 (it)
SI (1) SI2699545T1 (it)
SM (1) SMT201600284B (it)
WO (1) WO2012143660A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104995171B (zh) * 2012-12-19 2018-02-06 拜耳作物科学股份公司 作为杀真菌剂的二氟甲基‑烟碱‑茚满基甲酰胺
WO2023084054A1 (en) 2021-11-12 2023-05-19 3Z Ehf Treatment of adhd using selective binders of the 11-imidazoline receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670859A1 (de) * 1967-04-24 1971-03-11 Bayer Ag Verfahren zur Herstellung von 2-Phenyl-imino-1-azacycloalkanen
US3679692A (en) * 1969-10-01 1972-07-25 Mead Johnson & Co Iminomethylindolines
US4533739A (en) 1982-10-12 1985-08-06 G. D. Searle & Co. 2-[(Aminophenyl and amidophenyl)amino]-1-azacycloalkanes having antidiarrheal activity
US4579951A (en) * 1984-03-19 1986-04-01 G. D. Searle & Co. Substituted (azacycloalk-2-yl)iminophenols and esters thereof
AU2010303545B2 (en) * 2009-10-06 2016-05-12 Allergan, Inc. 2H-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
KR20120098720A (ko) * 2009-10-21 2012-09-05 알러간, 인코포레이티드 알파 아드레날린 수용체 변형제

Also Published As

Publication number Publication date
JP5986625B2 (ja) 2016-09-06
PT2699545T (pt) 2016-08-30
HRP20161024T1 (hr) 2016-11-04
CA2833339A1 (fr) 2012-10-26
LT2699545T (lt) 2016-09-26
PL2699545T3 (pl) 2017-01-31
HUE030432T2 (en) 2017-05-29
RS55061B1 (sr) 2016-12-30
JP2014514316A (ja) 2014-06-19
WO2012143660A1 (fr) 2012-10-26
US9303019B2 (en) 2016-04-05
SI2699545T1 (sl) 2016-12-30
CN103619814B (zh) 2016-01-20
US20140045910A1 (en) 2014-02-13
EP2699545B1 (fr) 2016-05-25
CY1118117T1 (el) 2017-06-28
EP2699545A1 (fr) 2014-02-26
ES2588059T3 (es) 2016-10-28
CA2833339C (fr) 2020-09-15
DK2699545T3 (en) 2016-08-29
CN103619814A (zh) 2014-03-05

Similar Documents

Publication Publication Date Title
IL254422A0 (en) Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
SI2986304T1 (sl) Farmacevtski sestavek, postopki za zdravljenje in njegove uporabe
DK3329909T3 (da) Fenfluramin til anvendelse i behandling af dravet syndrom
PL3199024T3 (pl) Zastosowanie kompozycji cyklodekstryny i stosowne sposoby
PT2729151T (pt) Composição farmacêutica, métodos de tratamento e suas utilizações
IL244597A0 (en) Replication suppressors of influenza viruses, preparations containing them and their uses
HUE036583T2 (hu) Notch jelzõ folyamat inhibitorai és alkalmazásuk rákok kezelésében
BR112015001838A2 (pt) composições de inibidor de efluxo e métodos de tratamento utilizando o mesmo.
PT2898885T (pt) Derivados de pirrolopirimidina para utilização no tratamento de infeções virais
BR112015002524A2 (pt) derivados de alquilpirimidina para o tratamento de infecções virais e outras doenças.
DK2764084T4 (da) Anvendelse af phosphoketolase i fremstillingen af mevalonat, isoprenoid-udgangsstoffer, og isopren
DK2857039T3 (da) Terapeutisk middel eller profylaktisk middel mod demens
ITMI20131693A1 (it) Derivati della 1,4-cicloesilammina e loro preparazione
PL2830654T3 (pl) Sposoby i kompozycje do leczenia zapalenia
DK2861573T3 (da) Oxathiazin-derivater som antibakterielle og anticancer-stoffer
BR112013015891A2 (pt) uso de uma combinação, método de tratamento de um plasma e uso de uma combinação
HUE036523T2 (hu) Nem anti-koagulatív glikózaminoglikánok ismétlõdõ diszacharid egységgel és ezek gyógyászati alkalmazása
DK3074008T3 (da) Forbindelser, farmaceutisk sammensætning og fremgangsmåder til anvendelse i behandling af inflammation
HUE056434T2 (hu) Glikozaminoglikán vegyület, annak elõállítása és alkalmazása
EP2881444A4 (en) Water-repellent and oil-repellent composition and articles therewith
DK2688588T3 (da) Hurtig- og langtidsvirkende immunologisk terapeutisk middel
IL237803B (en) Extracts of cynara scolymus, coffea spp. and olea europaea for the treatment of metabolic syndrome
DK2984184T3 (da) Anvendelse af dnq eller dnq-87 i kombination med en parp1-inhibitor til behandlingen af cancer
BR112013023575A2 (pt) “derivado de octaidrotienoquinolina, composição farmacêutica compreendendo o derivado, e uso destes”
CL2015000537A1 (es) Siarn y su uso en los métodos y composiciones para el tratamiento y/o prevención de enfermedades de los ojos.